A man in his late thirties working with calm focus at a wooden desk by a bright window, with a notebook and a glass of water

Semax Nasal Spray and the Brain: What the Research Shows

A peptide nasal spray developed in Russia and talked about for focus. What it is, what the studies found, where the evidence runs thin, and where it stands with the FDA.

Key takeaways

  • Semax is a seven-amino-acid peptide based on a fragment of ACTH, taken as a nasal spray. It is approved as a medicine in Russia, not in the U.S.
  • In rats, a single dose raised BDNF, a protein that supports learning and nerve-cell connections, in the brain’s memory center.
  • Most human studies are Russian and in patients with stroke or other conditions; research in healthy adults is very limited.
  • It is not FDA-approved. In July 2026 an FDA advisory committee voted 8–5 to recommend allowing it in compounding, but the FDA has not yet acted.

Semax is a short peptide, seven amino acids long, developed in Russia in the 1980s and 1990s from a fragment of ACTH (adrenocorticotropic hormone). Its developers removed the hormone’s effects on stress hormones and kept the part linked to attention and memory, then added a short tail that makes it last longer. It is taken as a nasal spray, and in Russia it is an approved medicine, used mainly in stroke care (Ashmarin et al., 1997 (opens in a new tab)).

How it may work

The leading explanation involves BDNF (brain-derived neurotrophic factor), a protein that helps nerve cells survive, grow and form new connections, and that is central to learning. In rats, a single nasal dose of Semax raised BDNF protein in the hippocampus, the brain’s memory center, by up to 1.4 times and activated its receptor, and treated animals learned a conditioned task better (Dolotov et al., 2006 (opens in a new tab)).

Illustration of branching nerve cells exchanging glowing growth-factor signals at their connections
In rats, Semax raised levels of BDNF, a protein that helps nerve cells grow and connect.

What the human studies found

Who was studied

What was found

Healthy men under demanding conditions (Russian research summary)

Better attention and working memory reported, lasting up to about a day after a dose (Ashmarin et al., 1997)

24 healthy adults, average age 44, Semax or placebo

Brain scans showed changes in the default mode network, a brain system active during rest and reflection, within 20 minutes (Lebedeva et al., 2018)

Patients after ischemic stroke

Faster recovery of neurological function in early studies; in a 2018 study of 110 patients, Semax raised blood BDNF and improved daily-function scores during rehabilitation (Gusev et al., 1997; 2018)

These results are encouraging but limited. The healthy-adult scan study (Lebedeva et al., 2018 (opens in a new tab)) measured brain activity, not thinking performance. The stroke studies (Gusev et al., 1997 (opens in a new tab); Gusev et al., 2018 (opens in a new tab)) looked at recovery after brain injury, which is a different question from sharpening a healthy brain. A 2026 review of peptides in healthy aging grouped Semax with peptides that show promising early evidence but lack long-term safety data and rigorous trials (Mavrych et al., 2026 (opens in a new tab)).

Safety and side effects

Reported side effects include nasal irritation or dryness, headache, restlessness, irritability and trouble sleeping. Long-term safety in healthy adults hasn’t been established, and little is known about how it combines with stimulants, antidepressants or anxiety medicines.

Where it stands with the FDA

Semax is not FDA-approved. For U.S. pharmacies to compound it, the FDA must add it to the list of substances allowed in compounding. In July 2026, an FDA advisory committee voted 8–5 to recommend adding Semax for cognitive and neurological conditions, against the advice of FDA staff, who raised concerns about how well these peptides are characterized. The vote isn’t binding, and formal rulemaking is still required (DLA Piper, 2026 (opens in a new tab); FDA (opens in a new tab)).

Important

Avoid Semax sold online “for research use only.” These products aren’t made by licensed pharmacies, their contents and purity aren’t verified, and no provider reviews whether they are safe for you. Don’t use Semax if you are pregnant or breastfeeding, have a seizure disorder, a history of cancer or a serious psychiatric condition.

If you’re struggling with focus, the first steps are usually the least exciting: sleep, labs and a look at medicines and stress. THINKR’s providers start there, and can discuss prescription options for focus where appropriate.

References

  1. Ashmarin IP, et al. A nootropic adrenocorticotropin analog 4-10, Semax (15 years experience in its design and study). Zh Vyssh Nerv Deiat Im I P Pavlova. 1997;47(2):420-30. [In Russian] (opens in a new tab)

  2. Dolotov OV, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60. (opens in a new tab)

  3. Lebedeva IS, et al. Effects of Semax on the default mode network of the brain. Bull Exp Biol Med. 2018;165(5):653-6. (opens in a new tab)

  4. Gusev EI, et al. Effectiveness of Semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study). Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(6):26-34. [In Russian] (opens in a new tab)

  5. Gusev EI, et al. The efficacy of Semax in the treatment of patients at different stages of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(3 Pt 2):61-8. [In Russian] (opens in a new tab)

  6. Mavrych V, et al. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging. Front Aging. 2026;7:1790247. (opens in a new tab)

  7. DLA Piper. FDA AdComm recommends adding six peptides to bulk list. July 31, 2026. (opens in a new tab)

  8. U.S. Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A. (opens in a new tab)

Compounded medications are not FDA-approved. Prescriptions are issued only at a licensed provider’s discretion. This article is for information, not medical advice.

How we write

Articles are written by THINKR’s care team. They explain how care works and what research does and doesn’t show; they are general information, not medical advice, and your provider can tell you what applies to you. We update articles when guidance changes. Questions or corrections: support@thinkrmd.com.

Share this article

Frequently asked questions

Is Semax a stimulant?

No. It doesn’t work like caffeine or ADHD medicines. Research suggests it acts on BDNF, a growth factor in the brain, rather than simply making you more awake.

Has Semax been proven to improve focus in healthy people?

Not by the standards of large, independent clinical trials. Russian researchers reported better attention and memory in healthy men under demanding conditions, and a small brain-scan study found changes in brain network activity, but larger controlled studies in healthy adults are lacking.

Is Semax legal in the U.S.?

It is not an FDA-approved drug. Whether U.S. pharmacies can compound it depends on an FDA decision that is still pending after a July 2026 advisory committee vote. Avoid products sold “for research use only”, which have no prescription, medical review or pharmacy standards behind them.

All articles
01 / 02What’s your main goal?